ZBTB41
geneOn this page
Also known as FRBZ1FLJ36199DKFZp686C06120ZNF924
Summary
ZBTB41 (zinc finger and BTB domain containing 41, HGNC:24819) is a protein-coding gene on chromosome 1q31.3, encoding Zinc finger and BTB domain-containing protein 41 (Q5SVQ8). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.
Source: NCBI Gene 360023 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 99 total
- MANE Select transcript:
NM_194314
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24819 |
| Approved symbol | ZBTB41 |
| Name | zinc finger and BTB domain containing 41 |
| Location | 1q31.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FRBZ1, FLJ36199, DKFZp686C06120, ZNF924 |
| Ensembl gene | ENSG00000177888 |
| Ensembl biotype | protein_coding |
| Entrez | 360023 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 nonsense_mediated_decay
ENST00000367405, ENST00000467322, ENST00000868902, ENST00000958847
RefSeq mRNA: 1 — MANE Select: NM_194314
NM_194314
CCDS: CCDS30960
Canonical transcript exons
ENST00000367405 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001444438 | 197199354 | 197200590 |
| ENSE00001924721 | 197153682 | 197160014 |
| ENSE00003475427 | 197175010 | 197175115 |
| ENSE00003484898 | 197180988 | 197181117 |
| ENSE00003535711 | 197188292 | 197188439 |
| ENSE00003551325 | 197191692 | 197191899 |
| ENSE00003557958 | 197190762 | 197190831 |
| ENSE00003652886 | 197172160 | 197172248 |
| ENSE00003670845 | 197176564 | 197176670 |
| ENSE00003693216 | 197178417 | 197178512 |
| ENSE00003900197 | 197201223 | 197201293 |
Expression profiles
Bgee: expression breadth ubiquitous, 242 present calls, max score 96.64.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.7467 / max 172.2434, expressed in 1716 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 16499 | 9.1764 | 1704 |
| 16500 | 0.5703 | 235 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endothelial cell | CL:0000115 | 96.64 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 92.91 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 92.08 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 91.70 | gold quality |
| oviduct epithelium | UBERON:0004804 | 91.67 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 88.84 | gold quality |
| visceral pleura | UBERON:0002401 | 87.20 | gold quality |
| parietal pleura | UBERON:0002400 | 87.03 | gold quality |
| cerebellar vermis | UBERON:0004720 | 86.40 | gold quality |
| cortical plate | UBERON:0005343 | 86.06 | gold quality |
| islet of Langerhans | UBERON:0000006 | 85.87 | gold quality |
| tibia | UBERON:0000979 | 85.62 | gold quality |
| mammary duct | UBERON:0001765 | 85.54 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 85.48 | gold quality |
| ileal mucosa | UBERON:0000331 | 85.40 | gold quality |
| calcaneal tendon | UBERON:0003701 | 85.11 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 84.98 | gold quality |
| adrenal tissue | UBERON:0018303 | 84.82 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 84.51 | gold quality |
| primary visual cortex | UBERON:0002436 | 84.48 | gold quality |
| thymus | UBERON:0002370 | 84.24 | silver quality |
| medial globus pallidus | UBERON:0002477 | 83.90 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 83.74 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 83.65 | gold quality |
| corpus callosum | UBERON:0002336 | 83.62 | gold quality |
| skin of hip | UBERON:0001554 | 83.50 | gold quality |
| occipital lobe | UBERON:0002021 | 83.37 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.29 | gold quality |
| deltoid | UBERON:0001476 | 83.00 | gold quality |
| tendon | UBERON:0000043 | 82.94 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.36 |
| E-MTAB-6142 | no | 25.47 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2510.1 | ZBTB41 | Factors with multiple dispersed zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605320
miRNA regulators (miRDB)
440 targeting ZBTB41, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zbtb41 | ENSDARG00000054984 |
| mus_musculus | Zbtb41 | ENSMUSG00000033964 |
| rattus_norvegicus | Zbtb41 | ENSRNOG00000081235 |
Paralogs (51): WIZ (ENSG00000011451), ZNF416 (ENSG00000083817), MYNN (ENSG00000085274), PRDM4 (ENSG00000110851), PRDM2 (ENSG00000116731), ZBTB17 (ENSG00000116809), ZNF644 (ENSG00000122482), GZF1 (ENSG00000125812), ZNF426 (ENSG00000130818), ZNF287 (ENSG00000141040), ZNF697 (ENSG00000143067), ZNF687 (ENSG00000143373), ZNF214 (ENSG00000149050), ZNF547 (ENSG00000152433), ZNF776 (ENSG00000152443), ZNF230 (ENSG00000159882), ZNF222 (ENSG00000159885), ZNF233 (ENSG00000159915), ZNF333 (ENSG00000160961), ZNF319 (ENSG00000166188), ZNF592 (ENSG00000166716), ZNF646 (ENSG00000167395), ZNF507 (ENSG00000168813), ZNF768 (ENSG00000169957), ZNF417 (ENSG00000173480), ZNF408 (ENSG00000175213), ZNF223 (ENSG00000178386), ZNF852 (ENSG00000178917), ZNF784 (ENSG00000179922), ZNF572 (ENSG00000180938), ZNF707 (ENSG00000181135), ZNF746 (ENSG00000181220), ZNF467 (ENSG00000181444), ZNF530 (ENSG00000183647), ZNF17 (ENSG00000186272), ZNF527 (ENSG00000189164), ZKSCAN7 (ENSG00000196345), ZNF34 (ENSG00000196378), ZNF774 (ENSG00000196391), ZNF777 (ENSG00000196453)
Protein
Protein identifiers
Zinc finger and BTB domain-containing protein 41 — Q5SVQ8 (reviewed: Q5SVQ8)
All UniProt accessions (1): Q5SVQ8
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5SVQ8-1 | 1 | yes |
| Q5SVQ8-2 | 2 |
RefSeq proteins (1): NP_919290* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF00651
UniProt features (24 total): zinc finger region 14, compositionally biased region 3, splice variant 2, chain 1, domain 1, region of interest 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5SVQ8-F1 | 61.91 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 243 (showing top):
TGGTGCT_MIR29A_MIR29B_MIR29C, WWTAAGGC_UNKNOWN, ATTCTTT_MIR186, TGANTCA_AP1_C, DOUGLAS_BMI1_TARGETS_DN, TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P, NRF2_01, ETF_Q6, STAT1_02, SCGGAAGY_ELK1_02, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, MGGAAGTG_GABP_B, AAGCACA_MIR218, ETS_Q4, GCACTTT_MIR175P_MIR20A_MIR106A_MIR106B_MIR20B_MIR519D
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
702 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZBTB41 | SOWAHD | A6NJG2 | 580 |
| ZBTB41 | CFHR4 | Q92496 | 488 |
| ZBTB41 | PTAR1 | Q7Z6K3 | 440 |
| ZBTB41 | CFHR1 | Q03591 | 437 |
| ZBTB41 | CFHR5 | Q9BXR6 | 410 |
| ZBTB41 | NKAPL | Q5M9Q1 | 405 |
| ZBTB41 | SACS | Q9NZJ4 | 390 |
| ZBTB41 | HELZ | P42694 | 377 |
| ZBTB41 | SNX16 | P57768 | 373 |
| ZBTB41 | HABP2 | Q14520 | 363 |
| ZBTB41 | NFXL1 | Q6ZNB6 | 362 |
| ZBTB41 | NTHL1 | P78549 | 351 |
| ZBTB41 | POLE | Q07864 | 351 |
| ZBTB41 | RECQL | P46063 | 351 |
| ZBTB41 | KCNT2 | Q6UVM3 | 346 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| Evpl | RAD9A | psi-mi:“MI:0914”(association) | 0.350 |
| rl3_rl3l_human | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL36 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| ADARB1 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL13 | psi-mi:“MI:0914”(association) | 0.350 | |
| RPLP0 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL7A | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL13 | POLRMT | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (16): ZBTB41 (Affinity Capture-MS), ZBTB41 (Affinity Capture-MS), ZBTB41 (Affinity Capture-RNA), ZBTB41 (Affinity Capture-RNA), ZBTB41 (Affinity Capture-MS), ZBTB41 (Affinity Capture-MS), ZBTB41 (Affinity Capture-MS), ZBTB41 (Affinity Capture-MS), ZBTB41 (Affinity Capture-MS), ZBTB41 (Affinity Capture-MS), ZBTB41 (Cross-Linking-MS (XL-MS)), ZBTB41 (Cross-Linking-MS (XL-MS)), ZBTB41 (Cross-Linking-MS (XL-MS)), ZBTB41 (Affinity Capture-MS), ZBTB41 (Affinity Capture-RNA)
ESM2 similar proteins: A0JPB4, A1L1J6, A4IFJ6, D3ZUU2, E9Q8T2, G5E8B9, O08954, O15060, O42409, O43623, O57415, O70237, O75626, O95625, P19382, P25932, P36197, P37275, P97469, Q20082, Q2EI20, Q3MHQ4, Q3UH06, Q4VBD9, Q5DU09, Q5R9W9, Q5SVQ8, Q5T0B9, Q5ZLR2, Q60542, Q60636, Q62947, Q64318, Q6DCW1, Q6GNP2, Q6INV8, Q6NRM0, Q7TS63, Q7ZVR6, Q80X44
Diamond homologs: A1L2U9, A2A884, A2ANX9, B0X0K1, B0X9H6, B0XS89, B1WAZ8, B1WBU4, E9PZZ1, E9Q6W4, G5EBU4, O15090, O60315, O62836, O73694, O75362, O77459, P08048, P10925, P15822, P17010, P17012, P20662, P26635, P28166, P28575, P28698, P31509, P31629, P36197, P52739, P53243, P60319, P78871, P80944, Q00453, Q00900, Q01800, Q02026, Q02027
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
99 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 78 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1116 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:197167790:A:C | donor_gain | 1.0000 |
| 1:197167849:T:A | donor_gain | 1.0000 |
| 1:197175005:CTTA:C | donor_gain | 1.0000 |
| 1:197175006:TTACT:T | donor_loss | 1.0000 |
| 1:197175007:TAC:T | donor_loss | 1.0000 |
| 1:197175008:A:AC | donor_gain | 1.0000 |
| 1:197175009:C:A | donor_loss | 1.0000 |
| 1:197175009:C:CA | donor_gain | 1.0000 |
| 1:197175009:CT:C | donor_gain | 1.0000 |
| 1:197175009:CTT:C | donor_gain | 1.0000 |
| 1:197175009:CTTT:C | donor_gain | 1.0000 |
| 1:197175009:CTTTT:C | donor_gain | 1.0000 |
| 1:197175113:CACCT:C | acceptor_gain | 1.0000 |
| 1:197175115:CCT:C | acceptor_gain | 1.0000 |
| 1:197175115:CCTTA:C | acceptor_loss | 1.0000 |
| 1:197175116:C:CC | acceptor_gain | 1.0000 |
| 1:197175117:T:C | acceptor_gain | 1.0000 |
| 1:197175117:T:TC | acceptor_gain | 1.0000 |
| 1:197175122:A:AC | acceptor_gain | 1.0000 |
| 1:197176559:TATAC:T | donor_loss | 1.0000 |
| 1:197176560:ATAC:A | donor_loss | 1.0000 |
| 1:197176561:TA:T | donor_loss | 1.0000 |
| 1:197176563:C:CT | donor_loss | 1.0000 |
| 1:197176666:GAAGT:G | acceptor_gain | 1.0000 |
| 1:197176667:AAGT:A | acceptor_gain | 1.0000 |
| 1:197176668:AGT:A | acceptor_gain | 1.0000 |
| 1:197176669:GT:G | acceptor_gain | 1.0000 |
| 1:197176670:TCTA:T | acceptor_loss | 1.0000 |
| 1:197176671:C:CC | acceptor_gain | 1.0000 |
| 1:197176671:C:CG | acceptor_loss | 1.0000 |
AlphaMissense
6074 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:197159873:A:G | L739P | 1.000 |
| 1:197159890:A:C | F733L | 1.000 |
| 1:197159890:A:T | F733L | 1.000 |
| 1:197159891:A:G | F733S | 1.000 |
| 1:197159892:A:G | F733L | 1.000 |
| 1:197159913:A:G | C726R | 1.000 |
| 1:197159935:A:C | H718Q | 1.000 |
| 1:197159935:A:T | H718Q | 1.000 |
| 1:197159947:G:C | H714Q | 1.000 |
| 1:197159947:G:T | H714Q | 1.000 |
| 1:197159974:A:C | F705L | 1.000 |
| 1:197159974:A:T | F705L | 1.000 |
| 1:197159975:A:G | F705S | 1.000 |
| 1:197159976:A:G | F705L | 1.000 |
| 1:197159986:G:C | C701W | 1.000 |
| 1:197159987:C:T | C701Y | 1.000 |
| 1:197159988:A:G | C701R | 1.000 |
| 1:197159997:A:G | C698R | 1.000 |
| 1:197172226:A:G | C670R | 1.000 |
| 1:197175058:A:G | L646P | 1.000 |
| 1:197175075:A:C | F640L | 1.000 |
| 1:197175075:A:T | F640L | 1.000 |
| 1:197175077:A:G | F640L | 1.000 |
| 1:197175098:A:G | C633R | 1.000 |
| 1:197176590:A:G | L618P | 1.000 |
| 1:197176607:A:C | F612L | 1.000 |
| 1:197176607:A:T | F612L | 1.000 |
| 1:197176608:A:G | F612S | 1.000 |
| 1:197176609:A:G | F612L | 1.000 |
| 1:197176630:A:G | C605R | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000014055 (1:197183434 C>G), RS1000146916 (1:197153219 T>C), RS1000150979 (1:197183650 C>A,G), RS1000289961 (1:197154041 C>T), RS1000299612 (1:197168924 G>A), RS1000381008 (1:197182697 G>T), RS1000412567 (1:197195633 G>A,C), RS1000455808 (1:197162649 T>TA), RS1000511399 (1:197163595 G>A), RS1000582973 (1:197157393 T>C), RS1000608929 (1:197202747 G>T), RS1000635424 (1:197157077 C>T), RS1000636632 (1:197170781 A>C), RS1000650654 (1:197189325 A>G), RS1000788454 (1:197164015 A>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001899_1 | Age-related macular degeneration | 1.000000e-16 |
| GCST002479_5 | Lupus nephritis in systemic lupus erythematosus | 5.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
36 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, increases expression, affects expression | 6 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 2 |
| Air Pollutants | affects cotreatment, decreases expression, increases abundance | 2 |
| Tetrachlorodibenzodioxin | affects expression, decreases expression | 2 |
| Aflatoxin B1 | affects expression, decreases methylation | 2 |
| aristolochic acid I | decreases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| alpha-pinene | affects cotreatment, decreases expression, increases abundance | 1 |
| butyraldehyde | decreases expression | 1 |
| methacrylaldehyde | affects cotreatment, decreases expression, increases abundance | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| fenpyroximate | decreases expression | 1 |
| 4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide | decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| picoxystrobin | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Acrolein | affects cotreatment, decreases expression, increases abundance | 1 |
| Antimycin A | decreases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Gold | decreases expression | 1 |
| Indomethacin | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Niclosamide | increases expression | 1 |
| Ozone | affects cotreatment, decreases expression, increases abundance | 1 |
| Plant Extracts | increases expression, affects cotreatment | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): age-related macular degeneration, glaucoma, lupus nephritis